Jpmorgan Chase & CO Stevanato Group S.P.A. Transaction History
Jpmorgan Chase & CO
- $1.23 Trillion
- Q4 2024
A detailed history of Jpmorgan Chase & CO transactions in Stevanato Group S.P.A. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 606 shares of STVN stock, worth $12,665. This represents 0.0% of its overall portfolio holdings.
Number of Shares
606
Previous 6,458
90.62%
Holding current value
$12,665
Previous $129,000
89.92%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding STVN
# of Institutions
137Shares Held
55.5MCall Options Held
700Put Options Held
600-
Conestoga Capital Advisors, LLC8.08MShares$169 Million2.35% of portfolio
-
Neuberger Berman Group LLC New York, NY4.64MShares$96.9 Million0.08% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.3MShares$69.1 Million0.04% of portfolio
-
Times Square Capital Management, LLC3.29MShares$68.7 Million1.1% of portfolio
-
Thrivent Financial For Lutherans Minneapolis, MN2.78MShares$58 Million0.12% of portfolio
About Stevanato Group S.p.A.
- Ticker STVN
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 264,700,000
- Market Cap $5.53B
- Description
- Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machine...